R M Eickhoff1, J Steinbusch2, P Seppelt2, A Kroh2, K Junge3, C D Klink2, U P Neumann2, M Binnebösel2. 1. Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Uniklinik RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland. reickhoff@ukaachen.de. 2. Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Uniklinik RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland. 3. Klinik für Allgemein-, Viszeral- und Minimalinvasive Chirurgie, Medizinisches Zentrum der Städte Region Aachen, Aachen, Deutschland.
Abstract
BACKGROUND: Among patients with necrotizing pancreatitis 15-20% develop infected necrosis, which entails mortality rates of up to 20%. Particularly driven by the results of the Dutch Pancreatitis Study Group there has been a paradigm change from open necrosectomy to step-up treatment with initial percutaneous and/or endoscopic drainage followed, if necessary, by minimally invasive retroperitoneal debridement. AIM OF THE STUDY: Description of case series in which patients underwent video-assisted retroperitoneal debridement (VARD) including follow-up focused on quality of life. METHODS: Systematic cohort study including all patients who underwent a VARD procedure at the Department of General, Visceral and Transplantation Surgery at Aachen University Hospital from 2011 to 2015. Quality of life was recorded using the EORTC QLQ-C 30 questionnaire and compared to a representative sample of the German general population. RESULTS: The VARD procedure was performed in 9 cases, although in 1 case conversion to an open approach due to an acute bleeding was necessary. There was no 30-day and 60-day mortality following VARD. During the postoperative stay no patient required specific treatment for surgical complications. In particular, no enterocutaneous fistula or organ perforation was observed. Regarding the quality of life score there was no significant difference concerning the global health status, compared to the sample from the general population. DISCUSSION: Our data reinforce that a step-up approach in patients with necrotizing pancreatitis is a feasible and safe treatment procedure. For the first time, we could demonstrate satisfactory results in a long-term follow-up including QOL.
BACKGROUND: Among patients with necrotizing pancreatitis 15-20% develop infected necrosis, which entails mortality rates of up to 20%. Particularly driven by the results of the Dutch Pancreatitis Study Group there has been a paradigm change from open necrosectomy to step-up treatment with initial percutaneous and/or endoscopic drainage followed, if necessary, by minimally invasive retroperitoneal debridement. AIM OF THE STUDY: Description of case series in which patients underwent video-assisted retroperitoneal debridement (VARD) including follow-up focused on quality of life. METHODS: Systematic cohort study including all patients who underwent a VARD procedure at the Department of General, Visceral and Transplantation Surgery at Aachen University Hospital from 2011 to 2015. Quality of life was recorded using the EORTC QLQ-C 30 questionnaire and compared to a representative sample of the German general population. RESULTS: The VARD procedure was performed in 9 cases, although in 1 case conversion to an open approach due to an acute bleeding was necessary. There was no 30-day and 60-day mortality following VARD. During the postoperative stay no patient required specific treatment for surgical complications. In particular, no enterocutaneous fistula or organ perforation was observed. Regarding the quality of life score there was no significant difference concerning the global health status, compared to the sample from the general population. DISCUSSION: Our data reinforce that a step-up approach in patients with necrotizing pancreatitis is a feasible and safe treatment procedure. For the first time, we could demonstrate satisfactory results in a long-term follow-up including QOL.
Authors: Michael G T Raraty; Christopher M Halloran; Susanna Dodd; Paula Ghaneh; Saxon Connor; Jonathan Evans; Robert Sutton; John P Neoptolemos Journal: Ann Surg Date: 2010-05 Impact factor: 12.969
Authors: Werner Hartwig; Sasa-Marcel Maksan; Thomas Foitzik; Jan Schmidt; Christian Herfarth; Ernst Klar Journal: J Gastrointest Surg Date: 2002 May-Jun Impact factor: 3.452
Authors: Hjalmar C van Santvoort; Marc G Besselink; Olaf J Bakker; H Sijbrand Hofker; Marja A Boermeester; Cornelis H Dejong; Harry van Goor; Alexander F Schaapherder; Casper H van Eijck; Thomas L Bollen; Bert van Ramshorst; Vincent B Nieuwenhuijs; Robin Timmer; Johan S Laméris; Philip M Kruyt; Eric R Manusama; Erwin van der Harst; George P van der Schelling; Tom Karsten; Eric J Hesselink; Cornelis J van Laarhoven; Camiel Rosman; Koop Bosscha; Ralph J de Wit; Alexander P Houdijk; Maarten S van Leeuwen; Erik Buskens; Hein G Gooszen Journal: N Engl J Med Date: 2010-04-22 Impact factor: 91.245
Authors: A Kleespies; W E Thasler; C Schäfer; G Meimarakis; M E Eichhorn; C J Bruns; K-W Jauch; N Zügel Journal: Z Gastroenterol Date: 2008-08 Impact factor: 2.000
Authors: Martin L Freeman; Jens Werner; Hjalmar C van Santvoort; Todd H Baron; Marc G Besselink; John A Windsor; Karen D Horvath; Eric vanSonnenberg; Thomas L Bollen; Santhi Swaroop Vege Journal: Pancreas Date: 2012-11 Impact factor: 3.327
Authors: D W da Costa; D Boerma; H C van Santvoort; K D Horvath; J Werner; C R Carter; T L Bollen; H G Gooszen; M G Besselink; O J Bakker Journal: Br J Surg Date: 2013-11-22 Impact factor: 6.939
Authors: Sandra van Brunschot; Janneke van Grinsven; Rogier P Voermans; Olaf J Bakker; Marc G H Besselink; Marja A Boermeester; Thomas L Bollen; Koop Bosscha; Stefan A Bouwense; Marco J Bruno; Vincent C Cappendijk; Esther C Consten; Cornelis H Dejong; Marcel G W Dijkgraaf; Casper H van Eijck; G Willemien Erkelens; Harry van Goor; Mohammed Hadithi; Jan-Willem Haveman; Sijbrand H Hofker; Jeroen J M Jansen; Johan S Laméris; Krijn P van Lienden; Eric R Manusama; Maarten A Meijssen; Chris J Mulder; Vincent B Nieuwenhuis; Jan-Werner Poley; Rogier J de Ridder; Camiel Rosman; Alexander F Schaapherder; Joris J Scheepers; Erik J Schoon; Tom Seerden; B W Marcel Spanier; Jan Willem A Straathof; Robin Timmer; Niels G Venneman; Frank P Vleggaar; Ben J Witteman; Hein G Gooszen; Hjalmar C van Santvoort; Paul Fockens Journal: BMC Gastroenterol Date: 2013-11-25 Impact factor: 3.067